
Broadview Ventures is a mission-driven venture philanthropy organization created by the Leducq Charitable Trust, providing seed and early-stage equity funding to companies developing innovative technologies for the diagnosis and treatment of cardiovascular disease and stroke. Headquartered in Boston, it invests across therapeutics, devices, diagnostics, and digital health from pre-clinical through clinical proof-of-concept stages.
56% of their portfolio is in Healthcare. Their most common stage is series-a (48% of deals). Average disclosed round size is $21.8M (across 20 rounds with reported amounts).
Portfolio
23
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
27 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Growth | $75M | Oct 2025 | |
| Series A | $80M | Jun 2025 | |
| MMosanna | Series A | $80M | Jan 2025 |
| NNyra Medical, Inc. | Series A | $20M | Nov 2022 |
| Series A | $30M | May 2022 | |
| Series A | — | Jan 2022 | |
| AAlveron Pharma | Seed | — | Jan 2019 |
| Series A | $11M | Jan 2019 | |
| RRenovacor | Series A | $11M | Jan 2019 |
| RRenovacor | Series A | $11M | Jan 2019 |
| Series A | — | Feb 2017 | |
| Seed | — | Nov 2016 | |
| Series B | $11M | Jan 2015 | |
| Series B | $8M | Jan 2014 | |
| Unknown | $3.2M | Sep 2013 | |
| Series A | $3.2M | Jan 2013 | |
| Unknown | $20M | Jan 2012 | |
| Seed | $1.1M | Jan 2010 | |
| Series B | $17M | — | |
| Series B | $16M | — | |
| Series B | — | — | |
| Series A | $12M | — | |
| Series B | — | — | |
| CCellAegis Devices | Unknown | $9.5M | — |
| Series A | $12M | — |
Page 1 of 2
Top Co-Investors
New Leaf Venture Partners3 shared
Novartis Venture Fund3 shared
Innogest Capital3 shared
EQT Life Sciences2 shared
Forbion2 shared
Supermoon Capital2 shared
High-Tech Gründerfonds2 shared
Norwest Venture Partners2 shared
Safeguard Scientifics, Inc.2 shared
Excel Venture Management2 shared
Launchpad Capital2 shared
Enterprise Ireland2 shared
SOSV2 shared
Elkstone2 shared
Pivotal Life Sciences1 shared
Epidarex Capital1 shared
Vensana Capital1 shared
Health Catalyst Capital1 shared
Love Ventures1 shared
Terra Venture Partners1 shared
Last updated: 8 September 2026